The global Atipamezole Market, valued at approximately US$ 65 million in 2022, is projected to reach US$ 70 million by 2030, expanding at a compound annual growth rate (CAGR) of 1% from 2020 to 2030. Atipamezole, a synthetic alpha-2 adrenergic receptor antagonist, is primarily used in veterinary medicine to reverse sedative effects of drugs like de… Read More

The global Disinfectants Market, valued at over US$ 6.9 billion in 2019, is projected to expand at a compound annual growth rate (CAGR) of approximately 7% from 2020 to 2030. Disinfectants, used to eliminate pathogens on surfaces and in healthcare settings, have seen increased demand due to heightened hygiene awareness and infection control needs, … Read More

The global Radiopharmaceutical Theranostics Market, valued at US$ 3.0 billion in 2022, is projected to grow rapidly, advancing at a compound annual growth rate (CAGR) of 15.1% from 2023 to 2031, surpassing US$ 12.4 billion by the end of the forecast period. Theranostics combines diagnostics and therapy using radiopharmaceuticals, enabling targeted … Read More

The global Metformin Hydrochloride API Market is projected to reach US$ 500 million by 2031, expanding at a compound annual growth rate (CAGR) of approximately 5% from 2021 to 2031. Metformin hydrochloride, the active pharmaceutical ingredient (API) in metformin, is a cornerstone treatment for type 2 diabetes, valued for its efficacy and affordabil… Read More

The global Oral Transmucosal Drugs Market is projected to reach US$ 27 billion by 2031, expanding at a compound annual growth rate (CAGR) of approximately 6% from 2021 to 2031. Oral transmucosal drugs, administered through the mucous membranes of the mouth (e.g., sublingual, buccal), offer rapid absorption and are used for pain management, neurolog… Read More